Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Daiichi Eyes First-Line AML Filings For Vanflyta On Positive Data
Overcoming Past Later-Line Setbacks?
Jun 17 2022
•
By
Lisa Takagi
Daiichi Sankyo Plans Vanflyta Filings For First-Line AML • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from R&D
More from Scrip